These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26126457)

  • 1. Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resection.
    Okusanya OT; DeJesus EM; Jiang JX; Judy RP; Venegas OG; Deshpande CG; Heitjan DF; Nie S; Low PS; Singhal S
    J Thorac Cardiovasc Surg; 2015 Jul; 150(1):28-35.e1. PubMed ID: 26126457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas.
    Kennedy GT; Okusanya OT; Keating JJ; Heitjan DF; Deshpande C; Litzky LA; Albelda SM; Drebin JA; Nie S; Low PS; Singhal S
    Ann Surg; 2015 Oct; 262(4):602-9. PubMed ID: 26366539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization and Optimization of Intraoperative Molecular Imaging for Identifying Primary Pulmonary Adenocarcinomas.
    Predina JD; Okusanya O; D Newton A; Low P; Singhal S
    Mol Imaging Biol; 2018 Feb; 20(1):131-138. PubMed ID: 28497233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal model.
    Keating JJ; Runge JJ; Singhal S; Nims S; Venegas O; Durham AC; Swain G; Nie S; Low PS; Holt DE
    Cancer; 2017 May; 123(6):1051-1060. PubMed ID: 28263385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative Molecular Imaging of Lung Adenocarcinoma Can Identify Residual Tumor Cells at the Surgical Margins.
    Keating JJ; Okusanya OT; De Jesus E; Judy R; Jiang J; Deshpande C; Nie S; Low P; Singhal S
    Mol Imaging Biol; 2016 Apr; 18(2):209-18. PubMed ID: 26228697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer.
    Azari F; Kennedy G; Chang A; Nadeem B; Sullivan N; Marfatia I; Din A; Desphande C; Kucharczuk J; Delikatny EJ; Singhal S
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4406-4418. PubMed ID: 35876868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase I Clinical Trial of Targeted Intraoperative Molecular Imaging for Pulmonary Adenocarcinomas.
    Predina JD; Newton AD; Keating J; Dunbar A; Connolly C; Baldassari M; Mizelle J; Xia L; Deshpande C; Kucharczuk J; Low PS; Singhal S
    Ann Thorac Surg; 2018 Mar; 105(3):901-908. PubMed ID: 29397932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of Pulmonary Ground-Glass Opacities with Folate Receptor-Targeted Intraoperative Molecular Imaging.
    Predina JD; Newton A; Corbett C; Xia L; Sulyok LF; Shin M; Deshpande C; Litzky L; Barbosa E; Low PS; Kucharczuk JC; Singhal S
    J Thorac Oncol; 2018 Jul; 13(7):1028-1036. PubMed ID: 29626619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of OTL38-Generated Tumor-to-Background Ratio in Intraoperative Molecular Imaging-Guided Lung Cancer Resections.
    Azari F; Kennedy G; Bernstein E; Delikatny J; Lee JYK; Kucharczuk J; Low PS; Singhal S
    Mol Imaging Biol; 2023 Feb; 25(1):85-96. PubMed ID: 34101106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging-guided lung cancer resections.
    Azari F; Zhang K; Kennedy G; Bou-Samra P; Chang A; Nadeem B; Chang A; Galandarova A; Ibrahimli A; Karimov Z; Din A; Kucharczuk J; Doraid J; Pechet T; Delikatny E; Singhal S
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2453-2465. PubMed ID: 36905412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative Molecular Imaging Utilizing a Folate Receptor-Targeted Near-Infrared Probe Can Identify Macroscopic Gastric Adenocarcinomas.
    Newton AD; Predina JD; Frenzel-Sulyok LG; Low PS; Singhal S; Roses RE
    Mol Imaging Biol; 2021 Feb; 23(1):11-17. PubMed ID: 33033941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate receptor-targeted molecular imaging improves identification of malignancy during pulmonary resection: a case report.
    Predina JD; Newton A; Connolly C; Singhal S
    J Cardiothorac Surg; 2017 Dec; 12(1):110. PubMed ID: 29202877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
    Tummers QR; Hoogstins CE; Gaarenstroom KN; de Kroon CD; van Poelgeest MI; Vuyk J; Bosse T; Smit VT; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
    Oncotarget; 2016 May; 7(22):32144-55. PubMed ID: 27014973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative molecular imaging to identify lung adenocarcinomas.
    Newton AD; Kennedy GT; Predina JD; Low PS; Singhal S
    J Thorac Dis; 2016 Oct; 8(Suppl 9):S697-S704. PubMed ID: 28066672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis and histologic features of small pulmonary adenocarcinoma based on serum carcinoembryonic antigen level and computed tomographic findings.
    Takamochi K; Yoshida J; Nishimura M; Yokose T; Sasaki S; Nishiwaki Y; Suzuki K; Nagai K
    Eur J Cardiothorac Surg; 2004 May; 25(5):877-83. PubMed ID: 15082298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas.
    Predina JD; Newton AD; Connolly C; Dunbar A; Baldassari M; Deshpande C; Cantu E; Stadanlick J; Kularatne SA; Low PS; Singhal S
    Mol Ther; 2018 Feb; 26(2):390-403. PubMed ID: 29241970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic Antigen-Related Cell Adhesion Molecule Type 5 Receptor-Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer: A Nonrandomized Controlled Trial.
    Azari F; Meijer RPJ; Kennedy GT; Hanna A; Chang A; Nadeem B; Din A; Pèlegrin A; Framery B; Cailler F; Sullivan NT; Kucharczuk J; Martin LW; Vahrmeijer AL; Singhal S
    JAMA Netw Open; 2023 Jan; 6(1):e2252885. PubMed ID: 36705924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results.
    Yoshida J; Ishii G; Hishida T; Aokage K; Tsuboi M; Ito H; Yokose T; Nakayama H; Yamada K; Nagai K
    Jpn J Clin Oncol; 2015 Jul; 45(7):677-81. PubMed ID: 25900903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease.
    Gu B; Burt BM; Merritt RE; Stephanie S; Nair V; Hoang CD; Shrager JB
    Ann Thorac Surg; 2013 Aug; 96(2):411-8. PubMed ID: 23806231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.